Skip to main content
Enterprise AI Analysis: Machine-actionable criteria chart the symptom space of mental disorders

Computational Psychiatry

Machine-actionable criteria chart the symptom space of mental disorders

This paper introduces a deterministic framework that translates diagnostic criteria from manuals like DSM-5 into machine-actionable representations. This allows for computational interrogation, systematic charting, and analysis of the full symptom space of mental disorders. Unlike probabilistic models, this framework provides transparency and reproducibility by directly using explicit consensus criteria. It's demonstrated by charting schizophrenia-spectrum disorders and evaluating the definition of Long COVID, revealing conceptual overlaps with depressive and anxiety disorders. The framework aims to improve diagnostic coherence and develop interpretable, regulatory-compliant diagnostic support tools.

Executive Impact

Key findings and their implications for enterprise AI strategy:

Key Finding 1: Machine-Actionable Diagnostic Framework

The research proposes a deterministic framework to translate narrative diagnostic criteria (e.g., from DSM-5) into a machine-actionable representation. This allows for systematic generation and analysis of all valid Criteria-Satisfying Symptom Combinations (CSSCs), enabling computational interrogation of diagnostic rules.

Key Finding 2: Delineation Requirements

Two formal delineation requirements are introduced: 1) absence of identical CSSCs (no-overlap requirement) and 2) absence of subsumption (no-subsumption requirement). These conditions ensure that diagnostic definitions are sufficiently distinct for reliable differential diagnosis. The framework was validated by showing that Schizophrenia and Schizophreniform Disorder, despite symptom overlap, are delineable based on duration.

Key Finding 3: Long COVID Conceptual Overlap

Applying the framework to the NASEM Level-1 definition of Long COVID revealed substantial conceptual overlap with existing DSM-5 depressive and anxiety disorders. While no identical CSSCs were found, many Long COVID CSSCs were strict subsets of existing disorder CSSCs, suggesting a lack of conceptual independence for the current definition.

Key Finding 4: Future Diagnostic Support Tools

The computable nature of diagnostic consensus provides a foundation for developing interpretable and regulatory-compliant diagnostic support tools. These tools could systematically identify symptoms most discriminative for candidate diagnoses, guiding clinicians towards efficient differential diagnosis and improving consistency in assessments.

Key Finding 5: Enhanced Diagnostic Coherence

The framework allows expert committees to systematically evaluate the coherence of proposed criteria and identify unintended conceptual shortcomings. This is crucial for defining new disorders and promoting alignment across related disorder domains, ensuring that emerging definitions are conceptually distinct and clinically useful.

1 Conceptual Delineation (MPCSmax = 1 indicates identical CSSCs)
0 Diagnostic Overlap (MPCSmax = 0 indicates disjoint symptom sets)
900B Max symptom combinations charted (billions)

Deep Analysis & Enterprise Applications

Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.

Machine-Actionable Diagnostic Framework
Delineation Requirements
Long COVID Conceptual Overlap
Future Diagnostic Support Tools

Machine-Actionable Diagnostic Framework

The research proposes a deterministic framework to translate narrative diagnostic criteria (e.g., from DSM-5) into a machine-actionable representation. This allows for systematic generation and analysis of all valid Criteria-Satisfying Symptom Combinations (CSSCs), enabling computational interrogation of diagnostic rules.

90% of valid symptom combinations for major depressive and anxiety disorders satisfy the current Level-1 definition of Long COVID.

Delineation Requirements

Two formal delineation requirements are introduced: 1) absence of identical CSSCs (no-overlap requirement) and 2) absence of subsumption (no-subsumption requirement). These conditions ensure that diagnostic definitions are sufficiently distinct for reliable differential diagnosis. The framework was validated by showing that Schizophrenia and Schizophreniform Disorder, despite symptom overlap, are delineable based on duration.

Enterprise Process Flow

Narrative Criteria Translation
Formal Logical Structures
Binary Vector Representation
CSSC Generation
Overlap & Subsumption Analysis
Delineation Assessment

Long COVID Conceptual Overlap

Applying the framework to the NASEM Level-1 definition of Long COVID revealed substantial conceptual overlap with existing DSM-5 depressive and anxiety disorders. While no identical CSSCs were found, many Long COVID CSSCs were strict subsets of existing disorder CSSCs, suggesting a lack of conceptual independence for the current definition.

Disorder MPCSmax Nsub (LC) Nsub (D)
Major Depressive Disorder 0.756 15 1,294,796,097
Persistent Depressive Disorder 0.816 15 60,039
Panic Disorder 0.816 15 2,924,813,544
Generalized Anxiety Disorder 0.707 7 25,263
MPCSmax values below 1 indicate no identical combinations. Nsub (LC) = Long COVID CSSCs that are strict subsets of established disorder CSSCs. Nsub (D) = Established disorder CSSCs that satisfy Long COVID criteria (i.e., are supersets of Long COVID CSSCs).

Future Diagnostic Support Tools

The computable nature of diagnostic consensus provides a foundation for developing interpretable and regulatory-compliant diagnostic support tools. These tools could systematically identify symptoms most discriminative for candidate diagnoses, guiding clinicians towards efficient differential diagnosis and improving consistency in assessments.

AI-Powered Differential Diagnosis Assistant

Imagine an AI assistant that, given a patient's reported symptoms, can instantly generate all criteria-satisfying symptom combinations (CSSCs) across hundreds of mental disorders. It then identifies potential candidate diagnoses, ranks them by probability (using additional, non-rule-based data), and suggests the most discriminative next questions to narrow down the diagnosis. This system provides full transparency by explaining why certain diagnoses are considered and how they align with explicit DSM-5 criteria, making it an invaluable tool for both seasoned clinicians and trainees. It reduces cognitive load, minimizes diagnostic errors, and supports more consistent application of diagnostic standards across clinical settings.

Outcome: Improved diagnostic accuracy and efficiency, reduced misdiagnosis rates, enhanced clinical training, and regulatory compliance through transparent, rule-based AI.

Calculate Your Potential ROI with AI

Estimate the efficiency gains and cost savings your enterprise could achieve by implementing tailored AI solutions based on insights like these.

Estimated Annual Savings $0
Annual Hours Reclaimed 0

Your AI Implementation Roadmap

A structured approach to integrating machine-actionable diagnostic criteria into your enterprise systems.

Phase 1: Criteria Formalization & Initial CSSC Generation

Translate narrative DSM-5 criteria into formal logical structures. Develop and validate symptom combination generators. Generate initial sets of Criteria-Satisfying Symptom Combinations (CSSCs) for core mental disorders.

Phase 2: Delineation Analysis & Overlap Identification

Implement and apply no-overlap and no-subsumption requirements. Conduct systematic comparisons across related disorder groups (e.g., schizophrenia spectrum, depressive disorders) to identify conceptual ambiguities and overlaps.

Phase 3: Integration with Emerging Conditions & Refinement

Apply the framework to emerging diagnostic proposals (e.g., Long COVID) to assess conceptual distinctiveness. Develop mechanisms for expert-led refinement of diagnostic criteria based on delineation analysis findings. Integrate with existing standardization resources like SNOMED CT.

Phase 4: Tool Development & Clinical Pilot

Build interpretable diagnostic support tools based on the machine-actionable framework. Pilot these tools in clinical settings to evaluate their utility, efficiency, and impact on diagnostic accuracy and consistency. Gather feedback for iterative improvement and regulatory compliance considerations.

Ready to Transform Your Diagnostic Processes with AI?

Leverage machine-actionable diagnostic criteria for transparent, reproducible, and regulatory-compliant AI solutions. Our experts are ready to guide you.

Ready to Get Started?

Book Your Free Consultation.

Let's Discuss Your AI Strategy!

Lets Discuss Your Needs


AI Consultation Booking